SKVI — what changed in the latest 10-Q
A section-by-section comparison of SKVI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-05-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +9 | −14 | ~5 | 63 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~3 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-13
Our revenue, which we combine from product sales, royalties on patent licenses and license fees (product development fees), was $5,000 for the three months ended June 30, 2026 as compared with $5,000 for the same period ended June 30, 2025. Our revenue, which we combine from product sales, royalties…
Operating expenses were $117,817 for the three months ended June 30, 2026, as compared with $141,237 for the same period ended June 30, 2025. Operating expenses were $248,755 for the six months ended June 30, 2026, as compared with $286,089 for the same period ended June 30, 2025.
Our operating expenses for all periods consisted mainly of selling, general and administrative expenses. Our selling, general and administrative expenses for the three months ended June 30, 2026, consisted mainly of accrued salaries and wages of $86,463 and audit and accounting of $14,473. In compar…
We had other expenses of $142,716 for the three months ended June 30, 2026, compared with other expense of $138,190 for the three months ended June 30, 2025. We had other expenses of $283,962 for the six months ended June 30, 2026, as compared with other expense of $279,343 for the six months ended …
Our other expense for the three months ended June 30, 2026 consisted mainly of interest expense of $142,716. Our other expense for the three months ended June 30, 2025 consisted mainly of interest expense of $142,720. Our other expense for the six months ended June 30, 2026 consisted mainly of inter…
Text removed vs the prior filing · source: 10-Q · 2026-05-13
Our revenue, which we combine from product sales, royalties on patent licenses and license fees (product development fees), was $5,000 for the three months ended March 31, 2026 as compared with $5,000 for the same period ended March 31, 2025.
We had $0 in cost of revenues for the three months ended March 31, 2026, compared with $0 in cost of revenues for the three months ended March 31, 2025, so our gross profit was $5,000 and $5,000 for the three months ended March 31, 2026 and 2025, respectively.
Operating expenses decreased to $130,938 for the three months ended March 31, 2026, from $144,852 for the same period ended March 31, 2025.
Our operating expenses for all periods consisted mainly of selling, general and administrative expenses.
Our selling, general and administrative expenses for the three months ended March 31, 2026, consisted mainly of accrued salaries and wages of $86,442 and audit and accounting of $18,110. In comparison, our selling, general and administrative expenses for the three months ended March 31, 2025, consis…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice